(Q34345218)

English

Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

13

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

6

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

4

object named as

Farhad Ravandi

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

12

object named as

Elias Jabbour

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gautam Borthakur

8

object named as

Gautam Borthakur

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Guillermo Garcia-Manero

14

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michael E Rytting

5

object named as

Michael Rytting

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

10

object named as

Monica Kwari

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Christopher B Benton

1

object named as

Christopher B Benton

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Deborah A Thomas

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hui Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anna R Franklin

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Samuel Dara

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sherry R Pierce

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

26 July 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

167

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

356-365

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Epigenomics of leukemia: from mechanisms to therapeutic applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Epigenetics of haematopoietic cell development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

DNA hypermethylation as a chemotherapy target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Dissecting DNA hypermethylation in cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Azacitidine: a review of its use in higher-risk myelodysplastic syndromes/acute myeloid leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Dose escalation methods in phase I cancer clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Epigenetics of acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Wnt/beta-catenin signaling in development and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

DNA methylation and gene silencing in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Decitabine in acute myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Decitabine in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

DNA methylation of multiple promoter-associated CpG islands in adult acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Cellular differentiation, cytidine analogs and DNA methylation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Design and analysis of phase I clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4198465

6 July 2018

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13050

21 January 2018

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13050

21 January 2018

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13050

21 January 2018

Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13050

21 January 2018

Preliminary results with 5-aza-2'-deoxycytidine (DAC)-containing chemotherapy in patients with relapsed or refractory acute leukemia. The EORTC Leukemia Cooperative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant DNA methylation of the Src kinase Hck, but not of Lyn, in Philadelphia chromosome negative acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cytarabine and decitabine in combination in human leukemic cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azacytidine as a novel agent in the treatment of acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypomethylating agents in acute lymphoblastic leukemia: untapped potential?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25066676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BJH.13050

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

release_ylx3btklhzfovgovaea2b26f4y

1 reference

https://api.fatcat.wiki/v0/release/ylx3btklhzfovgovaea2b26f4y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34345218&oldid=1858461890"